Skip to main content

Table 1 Observational associations between lipids and subsequent risk of chronic kidney disease

From: Understanding the relationship between circulating lipids and risk of chronic kidney disease: a prospective cohort study and large-scale genetic analyses

 

Primary analysis

Sensitivity analysis

Model 1

Model 2

Model 3

HDL-C

0.50(0.46–0.54)

0.68(0.61–0.75)

0.76(0.60–0.95)

0.78(0.62–0.99)

LDL-C

0.90(0.87–0.93)

0.97(0.94–1.01)

0.99(0.77–1.26)

1.01(0.79–1.29)

TC

0.89(0.87–0.92)

0.97(0.94–1.00)

0.98(0.79–1.21)

0.97(0.78–1.20)

TG

1.13(1.11–1.16)

1.10(1.06–1.13)

1.08(1.02–1.13)

1.07(1.02–1.13)

  1. Hazard ratios (HRs) are provided with 95% confidence intervals
  2. Model 1: adjusted for age, sex, region, BMI, hypertension, diabetes mellitus, the top 10 genetic principal components
  3. Model 2: model1 + income, Townsend deprivation index, smoking, drinking, physical activity (IPAQ), sleep duration, antihypertensive medications usage at baseline and during follow-up, hypoglycemic medications usage at baseline and during follow-up
  4. Model 3: model1 + income, Townsend deprivation index, smoking, drinking, physical activity (IPAQ), sleep duration, antihypertensive medications usage at baseline and during follow-up, hypoglycemic medications usage at baseline and during follow-up, HDL-C, LDL-C, TC, and TG
  5. HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TC total cholesterol, TG triglycerides, IPAQ international physical activity questionnaire, BMI body mass index, HR hazard ratio